Please do not leave this page until complete. This can take a few moments.
Two more pharmacists who worked at the New England Compounding Center in Framingham have been convicted for their role in a deadly fungal meningitis outbreak in 2012 killing more than 100.
Both verification pharmacists at the facility were convicted of dispensing drugs without valid prescriptions with the intent to defraud or mislead government regulators. Kathy S. Chin of Canton was convicted on four counts, and Michelle L. Thomas of Cumberland, R.I., on two counts, with the convictions taking place Thursday in U.S. District Court in Boston.
The two pharmacists are scheduled to be sentenced in August.
Another court decision took place last week against another NECC employee.
Alla Stepanets of Framingham was sentenced to one year of probation. In December, Stepanets, a licensed pharmacist, who worked as another verification pharmacist at the center, was convicted of six counts of dispensing drugs without valid prescriptions. She was convicted of approving shipments of drugs for patients with fake names or celebrities.
Chin and Thomas were found to have approving shipments of drugs for patients with fictional or celebrity names. They routinely dispensed drugs without valid prescriptions.
Thursday's convictions of Chin and Thomas were the fourth and final trial resulting from 2014 indictments of those involved in the contaminated drug case, according to the U.S. Attorney's Office for Massachusetts, which announced the decisions. With their convictions, 13 defendants have now been convicted on 178 charges in the case.
In 2017, Barry Cadden, the former owner and head pharmacist for NECC, was sentenced to nine years in prison and three years of supervised release after being convicted of racketeering, mail fraud and other charges. Last year, Glenn Chin, NECC’s former supervisory pharmacist, was sentenced to eight years in prison and two years of supervised release after being convicted of 77 counts.
Stay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Sign upWorcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
SubscribeWorcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
See Digital EditionStay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
Worcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
1 Comments